SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is drawing intense community focus as investors weigh upcoming Phase 3 data catalysts for its lead psychiatric programs against concerns over cash burn and potential dilution. While some traders are bullish on the stock's clinical potential and institutional backing, others are actively debating management's track record and the long-term scalability of their psychedelic-based treatment models.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillow is facing significant downward pressure as investors react to an antitrust lawsuit filed by the FTC and several states over allegations of anti-competitive practices in rental advertising. The community is actively debating the stock's future, with many weighing the impact of legal risks against Zillow's strategic integration of AI and its position as a dominant, profitable leader in the housing market.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia is currently trending as investors monitor rapid Yutrepia product adoption and positive sales growth, while the community closely debates the potential impact of ongoing patent litigation and M&A speculation. Shareholders are largely focused on the company's competitive position against market peers and the anticipation of a pivotal legal ruling that could significantly shift the stock's valuation.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors debate its long-term potential, with bulls pointing to the brand's expanding real-world retail footprint and unique IP partnerships as reasons for optimism. While some community members remain frustrated by stagnant price action compared to the broader crypto market, others are actively accumulating tokens, betting that its utility and mainstream cultural reach will drive significant future gains.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is trending as investors monitor its pipeline and strategic moves in the obesity and immunology sectors, while the community heavily debates potential M&A activity involving the company and clinical-stage assets. Traders are actively discussing technical support levels and volume patterns alongside ongoing speculation about the company's competitive positioning against other major pharmaceutical firms.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis Corp is currently trending as the first major U.S. cannabis company to uplist to the NYSE, a milestone that has triggered intense discussion regarding institutional liquidity and potential regulatory shifts. The community is actively debating the company's valuation and strategic direction following the recent departure of a top executive, while closely monitoring market volatility related to broader sector index rebalancing.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is currently a focal point for investors debating whether its deeply depressed valuation at low forward price-to-earnings multiples represents a historic buying opportunity or a structural value trap in the face of legacy fintech disruption. While some market participants are aggressively accumulating shares and citing institutional backing, others are actively dumping the stock due to stalled revenue growth, high debt levels, and frustration over the company's long-term performance.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is currently a major focus for traders as they anticipate the upcoming Q1 earnings report and critical interim Phase 1 clinical data for its lead candidate, ABCL635. While the community is actively debating the stock's long-term potential versus its history of underperformance, strong institutional accumulation and notable analyst upgrades are driving significant volume and heightened short-interest volatility.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending as investors debate its long-term enterprise utility and corporate governing council structure against ongoing concerns regarding token supply dilution. The community remains deeply divided, with some actively accumulating at current levels in anticipation of regulatory developments and institutional adoption, while others express frustration over stagnant price action.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

ULTY is trending due to investor discourse surrounding the fund's recent 1-for-10 reverse stock split and a strategic shift in holdings toward large-cap blue chips to combat ongoing NAV erosion. The community remains deeply divided, with some investors focusing on high yield and potential recovery, while others criticize the fund's performance and payout volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ATRenew Q1 Earnings Call Highlights

ATRenew Inc. Reports Unaudited First Quarter 2026 Financial Results

ATRenew Inc. Reports Unaudited First Quarter 2026 Financial Results ATRenew Inc. Reports Unaudited First Quarter 2026 Financial Results PR Newswire SHANGHAI, May 19, 2026 SHANGHAI, May 19, 2026...

ATRenew to Report First Quarter 2026 Financial Results on May 19, 2026

ATRenew to Report First Quarter 2026 Financial Results on May 19, 2026 ATRenew to Report First Quarter 2026 Financial Results on May 19, 2026 PR Newswire SHANGHAI, May 6, 2026 SHANGHAI, May 6, 2026...

Precision Wealth Strategies LLC Makes New $1.33 Million Investment in ATRenew Inc. Sponsored ADR $RERE

Precision Wealth Strategies LLC bought a new stake in ATRenew Inc. Sponsored ADR (NYSE:RERE - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the...

ATRenew Inc. Files 2025 Annual Report on Form 20-F

ATRenew Inc. Files 2025 Annual Report on Form 20-F ATRenew Inc. Files 2025 Annual Report on Form 20-F PR Newswire SHANGHAI, April 8, 2026 SHANGHAI, April 8, 2026 /PRNewswire/ -- ATRenew Inc...

SG Americas Securities LLC Takes Position in ATRenew Inc. Sponsored ADR $RERE

SG Americas Securities LLC bought a new position in ATRenew Inc. Sponsored ADR (NYSE:RERE - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange...

ATRenew (NYSE:RERE) Trading Down 6.4%  - Time to Sell?

ATRenew (NYSE:RERE) Stock Price Down 6.4% - What's Next...

ATRenew Inc. Sponsored ADR (NYSE:RERE) Short Interest Up 44.9% in March

ATRenew Inc. Sponsored ADR (NYSE:RERE - Get Free Report) was the target of a large growth in short interest in the month of March. As of March 13th, there was short interest totaling 3,366,308...

ATRenew Inc. Sponsored ADR (NYSE:RERE) Announces Dividend of $0.10

ATRenew Inc. Sponsored ADR (NYSE:RERE) announced a dividend on Tuesday, March 10th. Stockholders of record on Monday, April 6th will be given a dividend of 0.10 per share on Friday, April 24th. The...

ATRenew Inc. Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results and Announces Cash Dividend

ATRenew Inc. Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results and Announces Cash Dividend ATRenew Inc. Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results and...

ATRenew Inc. is a consumer-oriented single service provider focused on sourcing electronic devices. It operates and manages a platform for pre-owned consumer electronics transactions and services. Its platform standardized and digitalized the mobile phone market by creating inspection, grading, and pricing processes. It procures its supply of pre-owned consumer electronics; processes devices for resale using proprietary inspection, grading, and pricing; and distributes processed devices to a variety of purchasers. It transacts with consumers and small merchants at both the supply and demand sides. The company was founded by Xue Feng Chen in 2011 and is headquartered in Shanghai, China.

Current Price	$3.93
Prev Close	$4.12
Open	$4.16
Dividend Yield	1.89%
50-Day Moving Average	$4.56
Beta	1.06
Avg. Volume	1.35M
PE Ratio	15.77

52-Week High	$6.47
52-Week Low	$2.67
Market Capitalization	$517.64M
EPS (Annual)	$0.1923
Price to Book	1.51
Revenue Per Employee	$1.23M

REREATRenew Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RERE News